These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 18580330

  • 1. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
    Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D.
    Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
    [Abstract] [Full Text] [Related]

  • 3. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Taupitz M, Böhmer D, Beyersdorff D.
    Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation.
    Franiel T, Lüdemann L, Rudolph B, Lutterbeck E, Hamm B, Beyersdorff D.
    AJR Am J Roentgenol; 2010 Mar; 194(3):675-81. PubMed ID: 20173144
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 8. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [Abstract] [Full Text] [Related]

  • 14. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
    Eyal E, Bloch BN, Rofsky NM, Furman-Haran E, Genega EM, Lenkinski RE, Degani H.
    Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
    [Abstract] [Full Text] [Related]

  • 15. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1).
    Bloch BN, Rofsky NM, Baroni RH, Marquis RP, Pedrosa I, Lenkinski RE.
    Acad Radiol; 2004 Aug; 11(8):863-7. PubMed ID: 15288036
    [Abstract] [Full Text] [Related]

  • 16. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE, Hutchinson CE, Buckley DL.
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [Abstract] [Full Text] [Related]

  • 17. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
    Carreira GC, Gemeinhardt O, Beyersdorff D, Schnorr J, Taupitz M, Lüdemann L.
    Magn Reson Imaging; 2009 Apr; 27(3):360-9. PubMed ID: 18768279
    [Abstract] [Full Text] [Related]

  • 18. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F, Beuvon F, Thévenin F, Chauveinc L, Vieillefond A, Descazeaux A, Flam T.
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [Abstract] [Full Text] [Related]

  • 19. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K.
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [Abstract] [Full Text] [Related]

  • 20. Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate.
    Prochnow D, Beyersdorff D, Warmuth C, Taupitz M, Gemeinhardt O, Lüdemann L.
    Magn Reson Imaging; 2005 Dec; 23(10):983-90. PubMed ID: 16376181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.